Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Eikon Therapeutics
AddedFeb 13, 2024
UpdatedJun 18, 2026
Eikon Therapeutics

Eikon Therapeutics

Series C

Eikon Therapeutics: A biopharmaceutical firm innovating novel treatments for critical diseases.

HQ
Hayward, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Eikon Therapeutics, founded to revolutionize the biopharmaceutical industry, focuses on discovering novel treatments for life-threatening diseases. The company's core mission is to leverage cutting-edge technology at the intersection of biology, engineering, and chemistry to develop innovative therapies. Eikon's market focus is on addressing critical medical needs by creating groundbreaking treatments that can significantly improve patient outcomes.

Notable figures affiliated with Eikon Therapeutics include leading scientists and industry experts who bring a wealth of experience to the company. The firm has garnered substantial investment from prominent venture capitalists, underscoring confidence in its innovative approach. Key achievements include significant advancements in drug discovery and development, positioning Eikon as a transformative player in the biopharmaceutical landscape.

Eikon Therapeutics - Similar Companies

Eikonizo Therapeutics logo

Eikonizo Therapeutics

eikonizo.com

Eikonoklastes Therapeutics logo

Eikonoklastes Therapeutics

eikonoklastes.com

Entrada Therapeutics logo

Entrada Therapeutics

entradatx.com

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

Symic Biomedical logo

Symic Biomedical

Eigen Therapeutics logo

Eigen Therapeutics

eigentx.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Bluejay Therapeutics logo

Bluejay Therapeutics

bluejaytx.com

EpiBiologics logo

EpiBiologics

epibiologics.com

Curie.Bio logo

Curie.Bio

curie.bio

Faze Medicines logo

Faze Medicines

fazemed.com

ECM Therapeutics logo

ECM Therapeutics

PineTree Therapeutics logo

PineTree Therapeutics

pinetreetx.com

Empirico logo

Empirico

empiricotx.com

Eikon Therapeutics - Quick Facts

Who are Eikon Therapeutics' competitors?

Companies similar to Eikon Therapeutics include Eikonizo Therapeutics, Eikonoklastes Therapeutics, Entrada Therapeutics and Triplet Therapeutics.

When was Eikon Therapeutics founded?

Eikon Therapeutics was founded in 2019.

Where is Eikon Therapeutics' headquarters located?

Eikon Therapeutics' headquarters is located in Hayward, CA, US.

When was Eikon Therapeutics' last funding round?

Eikon Therapeutics' most recent funding round was for $106M (USD) in June 2023.

How much has Eikon Therapeutics raised to-date?

As of Jun 1, 2023, Eikon Therapeutics has raised a total of $772M (USD).

How many employees does Eikon Therapeutics have?

Eikon Therapeutics has 374 employees as of Feb 5, 2024.

Eikon Therapeutics - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Biopharmaceuticals
Tags
  • SaaS
Unique IDs
  • ein: 842807586
  • secCik: 0001861123
  • ticker: EIKN
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified